Braskem S.A. Files November 2025 6-K Report
Ticker: BAK · Form: 6-K · Filed: Nov 14, 2025 · CIK: 1071438
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, disclosure
Related Tickers: BAK
TL;DR
Braskem S.A. (BAK) filed its monthly 6-K report on Nov 14, 2025, confirming its foreign private issuer status and Brazilian HQ.
AI Summary
Braskem S.A. filed a Form 6-K on November 14, 2025, for the month of November 2025. The filing indicates Braskem S.A. is a foreign private issuer and files annual reports under Form 20-F. The company's principal executive offices are located in Camacari, Bahia, Brazil.
Why It Matters
This filing provides routine disclosure for Braskem S.A. as a foreign private issuer, informing investors about its reporting status and location.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news that would immediately impact risk.
Key Players & Entities
- Braskem S.A. (company) — Filer of the 6-K report
- Camacari, Bahia, Brazil (location) — Principal executive offices location
- 20251114 (date) — Filing date of the report
- November 2025 (date) — Reporting period
FAQ
What is the primary purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, for the month of November 2025.
Under which form does Braskem S.A. file its annual reports?
Braskem S.A. files its annual reports under Form 20-F.
Where are Braskem S.A.'s principal executive offices located?
Braskem S.A.'s principal executive offices are located at Rua Eteno, 1561, Polo Petroquimico de Camacari, Camacari, Bahia - CEP 42810-000, Brazil.
What is the SEC file number for Braskem S.A.?
The SEC file number for Braskem S.A. is 001-14862.
Is Braskem S.A. submitting this Form 6-K in paper format?
The filing does not explicitly state whether the Form 6-K is being submitted in paper as permitted by Regulation S-T Rule 101(b)(1), with checkboxes left unchecked.
Filing Stats: 4,544 words · 18 min read · ~15 pages · Grade level 15.8 · Accepted 2025-11-13 21:11:29
Key Financial Figures
- $240,000,000.00 — n two hundred and forty million reais (R$240,000,000.00); (iii) deciding the Company’s Bu
- $480,000,000.00 — four hundred and eighty million reais (R$480,000,000.00), in accordance with the Company’
- $30,000,000.00 — nts greater than thirty million reais (R$30,000,000.00) per operation or higher, together, to
- $90,000,000.00 — er, together, to ninety million reais (R$90,000,000.00) per fiscal year, considering that this
Filing Documents
- bak20251113_6k3.htm (6-K) — 218KB
- bak202511136k3_001.jpg (GRAPHIC) — 3KB
- 0001292814-25-003968.txt ( ) — 223KB
From the Filing
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2025 (Commission File No. 1-14862 ) BRASKEM S.A. (Exact Name as Specified in its Charter) N/A (Translation of registrant's name into English) Rua Eteno, 1561, Polo Petroquimico de Camacari Camacari, Bahia - CEP 42810-000 Brazil (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ___X___ Form 40-F ______ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1). _____ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7). _____ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes ______ No ___X___ If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____. BRASKEM S.A. Corporate Taxpayer ID (CNPJ) No. 42.150.391/0001-70 Company Registry (NIRE) 29300006939 PUBLICLY HELD COMPANY MINUTES OF THE EXTRAORDINARY GENERAL MEETING HELD ON NOVEMBER 13, 2025 1. DATE, TIME AND PLACE : On November 13, 2025, at 3:00 p.m., in an exclusively digital manner, pursuant to article 5, paragraph 2, item I, and article 28, paragraphs 1, 2 and 3 of Brazilian Securities Commission (“ CVM ”) Resolution No. 81, of March 29, 2022 (“ CVM Resolution 81 ”), this Extraordinary General Meeting of BRASKEM S.A. (“ Meeting ” and “ Company ”, respectively) was considered held at the head office of the Company located at Rua Eteno, No. 1.561, Polo Industrial de Camaçari, City of Camaçari, 2. CALL NOTICE : Call Notice published in accordance with article 124 of Federal Law 6,404 of December 15, 1976 (“ Brazilian Corporations Law ”), in the “O Correio da Bahia” newspaper on October 14, 15 e 16, 2025, on pages 22, 11 e 09 respectively, and on the website of said (https://publicidadelegal.correio24horas.com.br/). 3. ATTENDANCE : Shareholders representing 97,91% (ninety-seven point ninety-one) of the common shares and 75,77% (seventy-five point seventy-seven) of the preferred shares issued by the Company participated in the Meeting, as verified by the information contained in the analytical maps prepared by the registrar, the central depository, and the Company itself, in accordance with article 48, item II of CVM Resolution 81, as per the records of the electronic remote participation system provided by the Company in accordance with article 47, item III of CVM Resolution 81. Other participant was Mr. Geraldo Vilaça, representative of the Company’s management, who was available to make any clarifications on the items of the Meeting agenda. 4. PRESIDING BOARD : After the legal quorum was verified, the Meeting was convened, with Mr. Felipe Guimarães Rosa Bon presiding over the Meeting and Ms. Lilian Porto Bruno acting as secretary, who were chosen pursuant to article 16, paragraph 3 of the Bylaws of the Company. 5. AGENDA : Discussion about: (i) replacement of one (1) effective member of the Company’s Board of Directors appointed by Novonor S.A. – Under Judicial Reorganization (“ Novonor ”) and by NSP Investimentos S.A. – Under Judicial Reorganization (“ NSP Inv. ”), to complete the remaining term of office, until the Annual General Meeting that will resolve on the Company’s financial statements for the fiscal year ending on December 31, 2025; (ii) amendment to article 2 of the Company's Bylaws, to improve its wording by aligning the description of the corporate purpose with the current reality of the activities performed by the Company; (iii) inclusion of a provision in the Company's Bylaws to detail the rules and procedures for the election of the Board of Directors; (iv) amendment to article 26 of the Company's Bylaws to: (a) update the approval thresholds of the Board of Directors; (b) authorize the Board of Directors to decide on the maintenance or monetary adjustment of such thresholds; and (c) remove from the Board of Directors’ responsibilities the selection and replacement of the independent auditors of the subsidiaries; e (v) due to the amendments resolved in items (ii) to (iv) above, resolve on the consolidation of the Company's Bylaws, including the renumbering of articles and paragraphs as applicable. 1 BRASKEM S.A. Corporate Taxpayer ID (CNPJ) No. 42.150.391/0001-70 Company Registry (NIRE) 29300006939 PUBLICLY HELD COMPANY